ID S7A13_HUMAN Reviewed; 470 AA. AC Q8TCU3; Q05C37; Q08AH9; Q96N84; DT 29-APR-2008, integrated into UniProtKB/Swiss-Prot. DT 01-JUN-2002, sequence version 1. DT 02-SEP-2026, entry version 151. DE RecName: Full=Solute carrier family 7 member 13; DE AltName: Full=Sodium-independent aspartate/glutamate transporter 1; DE AltName: Full=X-amino acid transporter 2; GN Name=SLC7A13; Synonyms=AGT1, XAT2; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY. RC TISSUE=Kidney; RX PubMed=11943479; DOI=10.1016/s0378-1119(02)00435-3; RA Blondeau J.-P.; RT "Homologues of amino acid permeases: cloning and tissue expression of XAT1 RT and XAT2."; RL Gene 286:241-248(2002). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT MET-249. RC TISSUE=Kidney; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT RP MET-249. RC TISSUE=Kidney; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). CC -!- FUNCTION: Associates with SLC3A1/rBAT to form a functional CC heterodimeric complex that transports anionic and neutral amino acids CC across the apical plasma membrane of renal epithelium. Preferentially CC mediates exchange transport, but can also operate via facilitated CC diffusion. May act as a major transporter for L-cystine in late CC proximal tubules, ensuring its reabsorption from the luminal fluid in CC exchange for cytosolic L-glutamate or L-aspartate. CC {ECO:0000250|UniProtKB:Q91WN3}. CC -!- CATALYTIC ACTIVITY: CC Reaction=L-cystine(out) + L-aspartate(in) = L-cystine(in) + L- CC aspartate(out); Xref=Rhea:RHEA:76299, ChEBI:CHEBI:29991, CC ChEBI:CHEBI:35491; Evidence={ECO:0000250|UniProtKB:Q91WN3}; CC -!- CATALYTIC ACTIVITY: CC Reaction=L-cystine(out) = L-cystine(in); Xref=Rhea:RHEA:76303, CC ChEBI:CHEBI:35491; Evidence={ECO:0000250|UniProtKB:Q91WN3}; CC -!- CATALYTIC ACTIVITY: CC Reaction=L-aspartate(in) + L-glutamate(out) = L-aspartate(out) + L- CC glutamate(in); Xref=Rhea:RHEA:76307, ChEBI:CHEBI:29985, CC ChEBI:CHEBI:29991; Evidence={ECO:0000250|UniProtKB:Q91WN3}; CC -!- CATALYTIC ACTIVITY: CC Reaction=L-aspartate(in) + L-glutamine(out) = L-aspartate(out) + L- CC glutamine(in); Xref=Rhea:RHEA:76311, ChEBI:CHEBI:29991, CC ChEBI:CHEBI:58359; Evidence={ECO:0000250|UniProtKB:Q91WN3}; CC -!- CATALYTIC ACTIVITY: CC Reaction=L-aspartate(in) + L-methionine(out) = L-aspartate(out) + L- CC methionine(in); Xref=Rhea:RHEA:76315, ChEBI:CHEBI:29991, CC ChEBI:CHEBI:57844; Evidence={ECO:0000250|UniProtKB:Q91WN3}; CC -!- CATALYTIC ACTIVITY: CC Reaction=L-leucine(out) + L-aspartate(in) = L-leucine(in) + L- CC aspartate(out); Xref=Rhea:RHEA:76319, ChEBI:CHEBI:29991, CC ChEBI:CHEBI:57427; Evidence={ECO:0000250|UniProtKB:Q91WN3}; CC -!- CATALYTIC ACTIVITY: CC Reaction=L-valine(out) + L-aspartate(in) = L-valine(in) + L- CC aspartate(out); Xref=Rhea:RHEA:76323, ChEBI:CHEBI:29991, CC ChEBI:CHEBI:57762; Evidence={ECO:0000250|UniProtKB:Q91WN3}; CC -!- CATALYTIC ACTIVITY: CC Reaction=L-aspartate(in) + L-phenylalanine(out) = L-aspartate(out) + L- CC phenylalanine(in); Xref=Rhea:RHEA:76327, ChEBI:CHEBI:29991, CC ChEBI:CHEBI:58095; Evidence={ECO:0000250|UniProtKB:Q91WN3}; CC -!- CATALYTIC ACTIVITY: CC Reaction=L-tyrosine(out) + L-aspartate(in) = L-tyrosine(in) + L- CC aspartate(out); Xref=Rhea:RHEA:76331, ChEBI:CHEBI:29991, CC ChEBI:CHEBI:58315; Evidence={ECO:0000250|UniProtKB:Q91WN3}; CC -!- CATALYTIC ACTIVITY: CC Reaction=L-tryptophan(out) + L-aspartate(in) = L-tryptophan(in) + L- CC aspartate(out); Xref=Rhea:RHEA:76335, ChEBI:CHEBI:29991, CC ChEBI:CHEBI:57912; Evidence={ECO:0000250|UniProtKB:Q91WN3}; CC -!- SUBUNIT: Disulfide-linked heterodimer composed of the catalytic light CC subunit SLC7A13 and the heavy subunit SLC3A1. CC {ECO:0000250|UniProtKB:Q91WN3}. CC -!- SUBCELLULAR LOCATION: Apical cell membrane CC {ECO:0000250|UniProtKB:Q91WN3}; Multi-pass membrane protein CC {ECO:0000255}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q8TCU3-1; Sequence=Displayed; CC Name=2; CC IsoId=Q8TCU3-2; Sequence=VSP_033067, VSP_033068, VSP_033069; CC -!- TISSUE SPECIFICITY: Expressed in the kidney. CC {ECO:0000269|PubMed:11943479}. CC -!- SIMILARITY: Belongs to the amino acid-polyamine-organocation (APC) CC superfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AJ417661; CAD10393.1; -; mRNA. DR EMBL; AK055815; BAB71021.1; -; mRNA. DR EMBL; CH471060; EAW91633.1; -; Genomic_DNA. DR EMBL; BC125165; AAI25166.1; -; mRNA. DR EMBL; BC125166; AAI25167.1; -; mRNA. DR EMBL; BC029436; AAH29436.1; ALT_TERM; mRNA. DR CCDS; CCDS34917.1; -. [Q8TCU3-1] DR RefSeq; NP_620172.2; NM_138817.3. [Q8TCU3-1] DR PDB; 8WK6; EM; 2.64 A; A/B=1-470. DR AlphaFoldDB; Q8TCU3; -. DR EMDB; EMD-37596; -. DR SMR; Q8TCU3; -. DR BioGRID; 127618; 9. DR FunCoup; Q8TCU3; 4. DR IntAct; Q8TCU3; 3. DR MINT; Q8TCU3; -. DR STRING; 9606.ENSP00000297524; -. DR TCDB; 2.A.3.8.24; the amino acid-polyamine-organocation (apc) family. DR iPTMnet; Q8TCU3; -. DR PhosphoSitePlus; Q8TCU3; -. DR BioMuta; SLC7A13; -. DR DMDM; 74751412; -. DR PaxDb; 9606-ENSP00000297524; -. DR PeptideAtlas; Q8TCU3; -. DR Antibodypedia; 54555; 4 antibodies from 4 providers. DR DNASU; 157724; -. DR Ensembl; ENST00000297524.8; ENSP00000297524.3; ENSG00000164893.9. [Q8TCU3-1] DR Ensembl; ENST00000419776.2; ENSP00000410982.2; ENSG00000164893.9. [Q8TCU3-2] DR GeneID; 157724; -. DR KEGG; hsa:157724; -. DR MANE-Select; ENST00000297524.8; ENSP00000297524.3; NM_138817.3; NP_620172.2. DR UCSC; uc003ydq.2; human. [Q8TCU3-1] DR AGR; HGNC:23092; -. DR ClinPGx; PA134980828; -. DR CTD; 157724; -. DR DisGeNET; 157724; -. DR GeneCards; SLC7A13; -. DR HGNC; HGNC:23092; SLC7A13. DR HPA; ENSG00000164893; Tissue enriched (kidney). DR MalaCards; SLC7A13; -. DR MIM; 617256; gene. DR OpenTargets; ENSG00000164893; -. DR VEuPathDB; HostDB:ENSG00000164893; -. DR eggNOG; KOG1287; Eukaryota. DR GeneTree; ENSGT00940000162798; -. DR HOGENOM; CLU_007946_3_0_1; -. DR InParanoid; Q8TCU3; -. DR OMA; EGSNWSW; -. DR OrthoDB; 9477746at2759; -. DR PAN-GO; Q8TCU3; 2 GO annotations based on evolutionary models. DR PhylomeDB; Q8TCU3; -. DR PathwayCommons; Q8TCU3; -. DR SignaLink; Q8TCU3; -. DR Agora; ENSG00000164893; -. DR BioGRID-ORCS; 157724; 9 hits in 1146 CRISPR screens. DR ChiTaRS; SLC7A13; human. DR GenomeRNAi; 157724; -. DR Pharos; Q8TCU3; Tdark. DR PRO; PR:Q8TCU3; -. DR Proteomes; UP000005640; Chromosome 8. DR RNAct; Q8TCU3; protein. DR Bgee; ENSG00000164893; Expressed in kidney epithelium and 36 other cell types or tissues. DR GO; GO:0016324; C:apical plasma membrane; ISS:UniProtKB. DR GO; GO:0005886; C:plasma membrane; IBA:GO_Central. DR GO; GO:0015179; F:L-amino acid transmembrane transporter activity; IBA:GO_Central. DR GO; GO:0046982; F:protein heterodimerization activity; IEA:Ensembl. DR GO; GO:0003333; P:amino acid transmembrane transport; IBA:GO_Central. DR GO; GO:0015810; P:aspartate transmembrane transport; IEA:Ensembl. DR GO; GO:0015811; P:L-cystine transport; IEA:Ensembl. DR GO; GO:0015813; P:L-glutamate transmembrane transport; IEA:Ensembl. DR FunFam; 1.20.1740.10:FF:000036; Solute carrier family 7 member 13; 1. DR Gene3D; 1.20.1740.10; Amino acid/polyamine transporter I; 1. DR InterPro; IPR002293; AA/rel_permease1. DR InterPro; IPR050598; AminoAcid_Transporter. DR PANTHER; PTHR11785; AMINO ACID TRANSPORTER; 1. DR PANTHER; PTHR11785:SF238; SOLUTE CARRIER FAMILY 7 MEMBER 13; 1. DR Pfam; PF13520; AA_permease_2; 1. DR PIRSF; PIRSF006060; AA_transporter; 1. DR PDBsum; 8WK6; -. PE 1: Evidence at protein level; KW 3D-structure; Alternative splicing; Amino-acid transport; Antiport; KW Cell membrane; Disulfide bond; Membrane; Reference proteome; Transmembrane; KW Transmembrane helix; Transport. FT CHAIN 1..470 FT /note="Solute carrier family 7 member 13" FT /id="PRO_0000330725" FT TOPO_DOM 1..11 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 12..32 FT /note="Helical; Name=1" FT /evidence="ECO:0000255" FT TOPO_DOM 33..45 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 46..66 FT /note="Helical; Name=2" FT /evidence="ECO:0000255" FT TOPO_DOM 67..87 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 88..108 FT /note="Helical; Name=3" FT /evidence="ECO:0000255" FT TOPO_DOM 109..128 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 129..149 FT /note="Helical; Name=4" FT /evidence="ECO:0000255" FT TOPO_DOM 150..162 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 163..183 FT /note="Helical; Name=5" FT /evidence="ECO:0000255" FT TOPO_DOM 184..206 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 207..227 FT /note="Helical; Name=6" FT /evidence="ECO:0000255" FT TOPO_DOM 228..240 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 241..261 FT /note="Helical; Name=7" FT /evidence="ECO:0000255" FT TOPO_DOM 262..287 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 288..308 FT /note="Helical; Name=8" FT /evidence="ECO:0000255" FT TOPO_DOM 309..336 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 337..357 FT /note="Helical; Name=9" FT /evidence="ECO:0000255" FT TOPO_DOM 358 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 359..379 FT /note="Helical; Name=10" FT /evidence="ECO:0000255" FT TOPO_DOM 380..393 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 394..414 FT /note="Helical; Name=11" FT /evidence="ECO:0000255" FT TOPO_DOM 415..421 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 422..442 FT /note="Helical; Name=12" FT /evidence="ECO:0000255" FT TOPO_DOM 443..470 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT VAR_SEQ 221..229 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_033067" FT VAR_SEQ 394..442 FT /note="VFLSFPLATIVIDVGLVVIPLVKSPNVHYVYVLLLVLSGLLFYIPLIHF -> FT SLILVVQAGEAGVQWHDLGLLQPLLPGFKRFSCLSLPSSWDYRCFCHFH (in FT isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_033068" FT VAR_SEQ 443..470 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_033069" FT VARIANT 249 FT /note="V -> M (in dbSNP:rs2976189)" FT /evidence="ECO:0000269|PubMed:14702039, FT ECO:0000269|PubMed:15489334" FT /id="VAR_042716" FT VARIANT 380 FT /note="R -> K (in dbSNP:rs4419794)" FT /id="VAR_042717" FT VARIANT 452 FT /note="M -> T (in dbSNP:rs9656982)" FT /id="VAR_042718" FT VARIANT 470 FT /note="E -> K (in dbSNP:rs9693999)" FT /id="VAR_042719" FT HELIX 17..27 FT /evidence="ECO:0007829|PDB:8WK6" FT HELIX 30..32 FT /evidence="ECO:0007829|PDB:8WK6" FT HELIX 34..40 FT /evidence="ECO:0007829|PDB:8WK6" FT TURN 41..43 FT /evidence="ECO:0007829|PDB:8WK6" FT HELIX 46..73 FT /evidence="ECO:0007829|PDB:8WK6" FT HELIX 77..87 FT /evidence="ECO:0007829|PDB:8WK6" FT HELIX 90..120 FT /evidence="ECO:0007829|PDB:8WK6" FT HELIX 121..123 FT /evidence="ECO:0007829|PDB:8WK6" FT STRAND 124..127 FT /evidence="ECO:0007829|PDB:8WK6" FT HELIX 128..130 FT /evidence="ECO:0007829|PDB:8WK6" FT HELIX 131..149 FT /evidence="ECO:0007829|PDB:8WK6" FT STRAND 150..152 FT /evidence="ECO:0007829|PDB:8WK6" FT HELIX 157..184 FT /evidence="ECO:0007829|PDB:8WK6" FT HELIX 187..190 FT /evidence="ECO:0007829|PDB:8WK6" FT TURN 191..193 FT /evidence="ECO:0007829|PDB:8WK6" FT HELIX 204..219 FT /evidence="ECO:0007829|PDB:8WK6" FT HELIX 225..228 FT /evidence="ECO:0007829|PDB:8WK6" FT TURN 234..237 FT /evidence="ECO:0007829|PDB:8WK6" FT HELIX 238..263 FT /evidence="ECO:0007829|PDB:8WK6" FT HELIX 266..271 FT /evidence="ECO:0007829|PDB:8WK6" FT HELIX 275..283 FT /evidence="ECO:0007829|PDB:8WK6" FT HELIX 290..318 FT /evidence="ECO:0007829|PDB:8WK6" FT HELIX 325..327 FT /evidence="ECO:0007829|PDB:8WK6" FT TURN 332..334 FT /evidence="ECO:0007829|PDB:8WK6" FT HELIX 338..353 FT /evidence="ECO:0007829|PDB:8WK6" FT HELIX 357..380 FT /evidence="ECO:0007829|PDB:8WK6" FT TURN 381..383 FT /evidence="ECO:0007829|PDB:8WK6" FT HELIX 386..388 FT /evidence="ECO:0007829|PDB:8WK6" FT STRAND 393..396 FT /evidence="ECO:0007829|PDB:8WK6" FT HELIX 397..416 FT /evidence="ECO:0007829|PDB:8WK6" FT HELIX 421..440 FT /evidence="ECO:0007829|PDB:8WK6" FT HELIX 447..460 FT /evidence="ECO:0007829|PDB:8WK6" SQ SEQUENCE 470 AA; 52114 MW; F8593B829E2050E7 CRC64; MDRGEKIQLK RVFGYWWGTS FLLINIIGAG IFVSPKGVLA YSCMNVGVSL CVWAGCAILA MTSTLCSAEI SISFPCSGAQ YYFLKRYFGS TVAFLNLWTS LFLGSGVVAG QALLLAEYSI QPFFPSCSVP KLPKKCLALA MLWIVGILTS RGVKEVTWLQ IASSVLKVSI LSFISLTGVV FLIRGKKENV ERFQNAFDAE LPDISHLIQA IFQGYFAYSG GACFTLIAGE LKKPRTTIPK CIFTALPLVT VVYLLVNISY LTVLTPREIL SSDAVAITWA DRAFPSLAWI MPFAISTSLF SNLLISIFKS SRPIYLASQE GQLPLLFNTL NSHSSPFTAV LLLVTLGSLA IILTSLIDLI NYIFFTGSLW SILLMIGILR RRYQEPNLSI PYKVFLSFPL ATIVIDVGLV VIPLVKSPNV HYVYVLLLVL SGLLFYIPLI HFKIRLAWFE KMTCYLQLLF NICLPDVSEE //